Proposal For Medtech Notified Bodies To Set Shop in Australia Gets Industry Support
This article was originally published in SRA
Executive Summary
Australia's medical device trade group, MTAA, has expressed support for most of the recommendations issued by a panel of experts appointed by the government to review the current state of medtech and drug regulations1-3. Among other things, the association is supporting proposals to allow third-party conformity assessment bodies to operate within Australia, establish an expedited pathway for the assessment of novel devices, and create a new comprehensive post-market monitoring scheme
You may also be interested in...
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.